COLUMBUS, Ohio (March 31, 2020)—Battelle announced today that it has deployed a system to decontaminate N95 respirator masks to State University of New York at Stony Brook on Long Island to meet the critical need of protecting healthcare workers on the frontline. It is in the final stages of assembly, will begin testing procedures and expected to start decontaminating up to 80,000 masks per day by the end of the week.
The CCDS Critical Care Decontamination System™ (CCDS™) uses concentrated, vapor phase hydrogen peroxide (VPHP) and works by exposing used respirator masks to the validated concentration level for 2.5 hours to decontaminate biological contaminates, including SARS-CoV-2.
Battelle has a fully operational system at its West Jefferson, Ohio facility that has processed test batches of previously worn PPE received from Central Ohio hospitals.
Negotiations are underway to place a second system at undisclosed location in the New York metropolitan area to address that city’s critical shortage of PPE needed by healthcare workers and first responders.
Battelle and Stony Brook University have a long-standing relationship; outside of their individual missions, together the two organizations comprise Brookhaven Science Associates, LLC (BSA) which since 1998, has been selected by the U.S. Department of Energy (DOE) to manage and operate Brookhaven National Laboratory.
The University offered the site as it seeks to meet the region’s growing need for essential PPE to address the growing number of confirmed cases of COVID-19.
“The Battelle team has been working around the clock for several weeks to build, test and get approval for this system so that we can mobilize to the areas of the country that need it the most, and clearly New York City is at the top of that list,” said Matt Vaughan, Battelle’s Contract Research President.
For decades, Battelle has served the military in protecting troops from chemical and biological hazards. The company operates Biosafety Level 2 and 3 labs where research is performed on live viruses, including SARS-CoV-2. Battelle also has a full medical device development team that works with the FDA on a regular basis.
Battelle CCDSTM is based on research that Battelle performed for the FDA in 2015 (Richter et al., 2016) to assess the feasibility to decontaminate N95 respirator masks in the event of a PPE shortage resulting from a pandemic. In that FDA study VPHP decontamination, using the same system parameters and critical end points as the current system, was shown to result in 6-log reduction of G. stearothermophilus while not degrading the filter performance of N95 respirators for multiple decontamination cycles. Battelle is currently conducting research to validate that other equipment, including surgical masks and ventilator components, can be decontaminated using this process.
Once the EUA is in place, Healthcare systems that are enrolled in the Battelle CCDSTM program will collect worn respirator masks daily in accordance with an approved procedure and courier them to one of the active Battelle CCDS Critical Care Decontamination SystemTM locations. The PPE will be labeled with a barcoded serial number for tracking the chain-of-custody throughout the process. This ensures that a hospital system receives its own masks back. Each respirator mask will be marked with the number of times that mask has been processed.
To learn more about Battelle CCDSTM, please visit www.battelle.org/decon or www.battelle.org/covidnews.
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org.
For more information contact Katy Delaney at (614) 424-7208 or at email@example.com or contact T.R. Massey at (614) 424-5544 or at firstname.lastname@example.org.